Subthalamic deep brain stimulation vs. intraduodenal levodopa infusion: A long-term retrospective comparative study
Objective: To analyze the long-term retrospective data of patients treated with Levodopa/carbidopa intestinal gel infusion (LCIG) and subthalamic nucleus deep brain stimulation (STN-DBS) in two…Improving provision of Parkinson’s disease exercise classes
Objective: (1) To identify common barriers and limitations related to the delivery of Parkinson's disease (PD) exercise classes; (2) To recommend interventions with widespread applicability…Auditory cues during obstacle crossing increase gait asymmetry in neurologically health individuals but not in people with Parkinson’s disease
Objective: To investigate the influence of auditory cue on gait asymmetry in an environment unobstructed and with obstacle in people with Parkinson's disease (PD) and…Utilization and longitudinal impact of amantadine use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
Objective: To evaluate baseline predictors and longitudinal impact of amantadine use in Parkinson's disease (PD). Background: There is preclinical data that amantadine has neuroprotective properties,…Status of NPF-QII after six years: Updates to the dataset
Objective: To describe the status and recent findings from the National Parkinson Foundation's Quality Improvement Initiative (NPF-QII), an 8,179 subject observational clinical study conducted at…Neural plasticity and freezing of gait: Stepping through the FoG
Objective: 1) To determine the efficacy of our cognitively challenging Agility Boot Camp (ABC-C) rehabilitation intervention and 2) to evaluate neural mechanisms and plasticity within…Classification and recommendation of nonpharmacological therapies for Parkinson’s disease
Objective: A multidisciplinary specialized treatment including physiotherapy, speech and language therapy, occupational therapy (OT) associated to the ideal pharmacological treatment and surgical is recommended to…Development of a human neuroblastoma model of pantothenate kinase-associated neurodegeneration
Objective: To establish a stable human neuronal model defective in PanK2. Background: Pantothenate Kinase-Associated Neurodegeneration (PKAN), is caused by mutations in PANK2, which encodes one…Stereotactic pallidotomy for Parkinson’s disease in El Salvador: One year follow up
Objective: Characterize patients with idiopathic Parkinson's disease undergoing posteroventral pallidotomy. Assess improvement in motor symptoms after pallidotomy. Background: Parkinson's disease is a neurodegenerative disease with…“Two odd targets” strategy in deep brain stimulation for Parkinson’s disease with unilateral dystonia
Objective: To describe a patient underwent deep brain stimulation (DBS) with different target in left and right. Background: DBS is a therapeutic option for movement…
- « Previous Page
- 1
- …
- 50
- 51
- 52
- 53
- 54
- …
- 207
- Next Page »